Cipla Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cipla Ltd with three other
companies in this sector in India:
Dr.Reddy's Laboratories Ltd
sales of 154.71 billion Indian Rupees [US$2.31 billion]
of which 83%
Cadila Healthcare Ltd
(98.38 billion Indian Rupees [US$1.47 billion]
of which 100%
was Pharmaceutical Products), and
Aurobindo Pharma Ltd
(138.96 billion Indian Rupees [US$2.07 billion]
Cipla Ltd reported sales of 136.78 billion Indian Rupees (US$2.04 billion)
March of 2016.
increase of 20.6%
versus 2015, when the company's sales were 113.45 billion Indian Rupees.
Sales at Cipla Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 123%).